Publications - Marius N. Stan, M.D.

Back to research profile

1. Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS. Cohort study on radioactive iodine-induced hypothyroidism: implications for graves' ophthalmopathy and optimal timing for thyroid hormone assessment. Thyroid. 2013 May; 23(5):620-5.
   View PubMed
2. Adhikari LJ, Sciallis AP, Reynolds JP, Jenkins S, Smith C, Stan M, Nassar A. Clinicopathologic Predictors of Thyroid Bed Recurrence of Differentiated Thyroid Cancer Using Ultrasound-Guided Fine-Needle Aspiration Biopsies. Thyroid. 2013 Feb 01. [Epub ahead of print]
   View PubMed
3. Bancos I, Grant CS, Nadeem S, Stan MN, Reading CC, Sebo TJ, Algeciras-Schimnich A, Singh RJ, Dean DS. Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract. 2012 Jul-Aug; 18(4):441-9.
   View PubMed
4. Stan MN, Ammash NM, Warnes CA, Brennan MD, Thapa P, Nannenga MR, Bahn RS. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease-A cohort study. Int J Cardiol. 2012 Mar 01. [Epub ahead of print]
   View PubMed
5. Stan MN, Garrity JA, Bahn RS. The evaluation and treatment of graves ophthalmopathy. Med Clin North Am. 2012 Mar; 96(2):311-28. Epub 2012 Feb 22.
   View PubMed
6. Stan MN, Hess EP, Bahn RS, Warnes CA, Ammash NM, Brennan MD, Thapa P, Montori VM. A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease. J Thyroid Res. 2012; 2012:210529. Epub 2012 Feb 12.
   View PubMed
7. Widmer RJ, Erickson D, Stan MN, McKusick MA, Garovic VD. Multiple causes for secondary hypertension in a young female. Nephology Reviews. 2012; 4(1).
8. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol. 2011 Jun; 46(3):155-63. Epub 2011 Apr 12.
   View PubMed
9. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association, American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011 Jun; 21(6):593-646. Epub 2011 Apr 21.
   View PubMed
10. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association, American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011 May-Jun; 17(3):456-520.
    View PubMed
11. Stan MN, Bahn RS. Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid. 2010 Jul; 20(7):777-83.
    View PubMed
12. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D, Sosa JA, Stan MN. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 2009 Jul; 19(7):673-4.
    View PubMed
13. Espiritu RP, Stan MN. Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancer. Endocr Pract. 2008 Nov; 14(8):1023-6.
    View PubMed
14. Stan MN, Garrity JA, Bradley EA, Woog JJ, Bahn MM, Brennan MD, Bryant SC, Achenbach SJ, Bahn RS. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy. J Clin Endocrinol Metab. 2006 Dec; 91(12):4817-24. Epub 2006 Sep 19
    View PubMed
15. Stan M, Morris JC. Thyrotropin-axis adaptation in aging and chronic disease. Endocrinol Metab Clin North Am. 2005 Dec; 34(4):973-92, x.
    View PubMed